Cigna Group Introduces Rebate-Free Pharmacy Benefit Model for Better Medication Access
- The Cigna Group's Evernorth launches a rebate-free pharmacy benefit model to improve medication affordability and transparency.
- David M. Cordani highlights upfront discounts on brand-name drugs, simplifying costs for consumers and health plans.
- Cigna Healthcare's new model aims to enhance consumer choice and support local pharmacies, rebuilding trust in pharmacy benefits.
Cigna Group Launches Innovative Pharmacy Benefit Model to Enhance Medication Access
On October 27, 2025, Evernorth, the health services arm of The Cigna Group, unveils a groundbreaking rebate-free pharmacy benefit model designed to alleviate the financial burden of prescription medications for Americans. This initiative marks a significant shift in the way pharmacy benefits are managed, prioritizing transparency and affordability. By eliminating the complex rebate system traditionally used in the pharmaceutical industry, Evernorth directly addresses the high costs associated with brand-name drugs, which have long posed challenges for consumers, despite the success of pharmacy benefit managers in reducing the costs of generics.
David M. Cordani, Chairman and CEO of The Cigna Group, acknowledges the enduring struggle with high brand-name drug prices, despite generics accounting for 90% of all prescriptions. He highlights that this new pharmacy benefit model, integrated within Evernorth's Express Scripts services, provides upfront discounts on medications, allowing individuals to benefit immediately at the pharmacy counter. This model not only simplifies the drug procurement process for businesses and health plans but also offers them enhanced visibility into their expenses, fostering a more straightforward approach to managing healthcare costs.
Adam Kautzner, President of Evernorth Care Management and Express Scripts, emphasizes that this initiative promotes greater consumer choice while encouraging the uptake of generics and biosimilars. As Cigna Healthcare prepares to implement this forward-thinking pharmacy benefit across its fully insured lines, the company reinforces its commitment to improving the healthcare experience for Americans. The focus on transparent pricing and support for local pharmacies aims to rebuild trust in pharmacy benefits, ensuring that essential medications remain accessible to all citizens.
In related news, Cigna Group is set to report its quarterly earnings on October 30, 2025. Analysts are keenly observing the company's performance, especially after it reported a revenue of $45.5 billion in the previous quarter, surpassing expectations. With a projected earnings per share (EPS) of around $5.20, reflecting a year-over-year increase, investors are looking for insights into Cigna's future growth strategies amidst evolving market conditions.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

